Pharmaceutical Updates

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its new state-of-the-art Technology Centre in Hyderabad, marking a significant milestone in...

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...

Johnson & Johnson Presents New Clinical Data Across Bipolar Mania, Depression and Schizophrenia

Johnson & Johnson announced the presentation of comprehensive new clinical and real-world data across its industry-leading neuropsychiatry portfolio...

Crackdown on Illegal cosmetics production in Mumbai: Maharashtra FDA seizes goods worth Rs 1 crore 53 lakhs

The Maharashtra Food and Drug Administration (FDA) has taken strict action against manufacturers and sellers of unlicensed and mislabelled cosmetics in the state. Till now FDA has seized a stock of illegal...

Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats

Novo Nordisk (Novo Nordisk A/S) the Danish multinational pharmaceutical major, earlier this week announced that the company had identified an IT security incident involving unauthorised access to a limited number of internal IT...

FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes

The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield® (teplizumab-mzwv) for children aged 8 to 17 years recently diagnosed with stage...

​The FDA has outlined its updated strategy for generic drug oversight

The U.S. Food and Drug Administration (FDA) announced its modernized framework for generic drug oversight, highlighting a dual focus on enforcing rigorous quality standards...

Orionis Biosciences Announces $1.44B Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines

Orionis Biosciences, a privately held, clinical-stage life sciences company pioneering proximity-induced therapeutic modalities, tl announced a multi-year collaboration with Novartis to discover and design molecular glue drugs...

India Dispatches 20,000 Vaccine Doses to Support Maldives’ Measles Outbreak Response

In a decisive demonstration of regional solidarity, the Government of India has dispatched 20,000 measles vaccine doses to the Republic of Maldives as the...